Lloyd Paul Aiello, MD, PhD, Professor of Ophthalmology at Harvard Medical School and Director of the Beetham Eye Institute at Joslin Diabetes Center, is the 2022 recipient of the Macula Society's...

Lloyd P. Aiello, MD, PhD, has been named the 2020 recipient of the prestigious Friedenwald Award from the Association for Research in Vision and Ophthalmology (ARVO). The Friedenwald Award was...

Lloyd Paul Aiello,  MD, PhD, Professor of Ophthalmology and Co-Director of the Diabetic Eye Disease Center of Excellence at Harvard Medical School, has been inducted into the Retina Hall of...

Boston - (June 12, 2017) – The Juvenile Diabetes Research Foundation (JDRF) has awarded Lloyd Paul Aiello, MD, PhD, the 2017 JDRF Mary Tyler Moore and S. Robert Levine Excellence in Clinical...

Lloyd Paul Aiello, MD, PhD, presented the Inaugural Kresge Eye Institute Robert N. Frank Clinical Translational Lecture, "From the Edges to the Depths of the Retina: Changing the Care of Diabetic Eye...

Faculty Recognition

Joseph Arboleda-Velasquez, MD, PhD, received a grant from the National Institute of Neurological Disorders and Stroke and National Institute of Aging/National Institutes of Health...

Anthony Adamis, MD; Lloyd Paul Aiello, MD, PhD; Claes Dohlman, MD, PhD; Evangelos Gragoudas, MD; Martine Jager, MD, PhD; and Joan W. Miller, MD, rank among the top 100 most influential people in...

Lloyd Paul Aiello, MD, PhD, Professor of Ophthalmology and Vice Chair of Centers of Excellence, will receive the 2016 Ernst H. Bárány Prize from the International Society of Eye Research (ISER). The...

In a study comparing imaging techniques used in an ocular telehealth program, Paolo Silva, MD, Lloyd Paul Aiello, MD, PhD, and colleagues at the Joslin Diabetes Center’s Beetham Eye Institute found...

In the 2015 Annual Meeting of the the Association for Research in Vision and Ophthalmology (ARVO), HMS Ophthalmology faculty and trainees will present 255 abstracts, including 35 papers, 188 posters...

Results of the DRCR.net Protocol T Study 

In the first clinical trial directly comparing three drugs most commonly used to treat diabetic macular edema, researchers found all were effective in...

World-renowned scientific award, often called the "Nobel Prize of Vision," recognizes the groundbreaking development of anti-angiogenic therapy for retinal disease

Jump to:
About the 2014...